Liraglutide plays an anti-inflammatory effect on LPS-induced ALI by suppressing the NLRP3 inflammasome pathway and inhibiting the activation of Rho/NF-κB signaling in HPMECs caused by LPS [22]. This evidence concerns the gene NLRP3 and acute respiratory distress syndrome.